SARS-CoV-2 infects brain astrocytes of COVID-19 patients and impairs neuronal viability
Abstract
COVID-19 patients may exhibit neuropsychiatric and neurological symptoms. We found that anxiety and cognitive impairment are manifested by 28-56% of SARS-CoV-2-infected individuals with mild respiratory symptoms and are associated with altered cerebral cortical thickness. Using an independent cohort, we found histopathological signs of brain damage in 25% of individuals who died of COVID-19. All of the affected brain tissues exhibited foci of SARS-CoV-2 infection and replication, particularly in astrocytes. Infection of neural stem cell-derived astrocytes changed energy metabolism, altered key proteins and metabolites used to fuel neurons and for biogenesis of neurotransmitters, and elicited a secretory phenotype that reduces neuronal viability. Our data support the model where SARS-CoV-2 reaches the brain, infects astrocytes and triggers neuropathological changes that contribute to the structural and functional alterations in the brain of COVID-19 patients.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
FAPESP (Sao Paulo Research Foundation; grants 2020/04746 0; 2017/25588 1; 2019/00098 7; 2014/10068 4; 2020/04919 2; 2013/08216 2; 2020/05601 6; 2020/04860 8; 2019/11457 8; 2013/07559 3; 2013/07607 8), Fundo de Apoio ao Ensino, Pesquisa e Extensao (FAEPEX) Unicamp Grant number: 2274/20, the Brazilian National Council for Scientific and Technological Development CNPq, and the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brazil (CAPES).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The neuropsychological evaluations and neuroimaging analyses were approved by the Research Ethics Committee of the University of Campinas (CAAE: 31556920.0.0000.5404) and all subjects signed a consent form to participate. The autopsy studies were approved by the National Commission for Research Ethics (CAAE:32475220.5.0000.5440 and CAAE: 38071420.0.1001.5404).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The mass spectrometry proteomic data have been deposited to the ProteomeXchange Consortium via the PRIDE 40 partner repository with the dataset identifier PXD021812 and 10.6019/PXD021812.
Subject Area
- Addiction Medicine (365)
- Allergy and Immunology (685)
- Anesthesia (183)
- Cardiovascular Medicine (2724)
- Dermatology (234)
- Emergency Medicine (411)
- Epidemiology (12378)
- Forensic Medicine (10)
- Gastroenterology (783)
- Genetic and Genomic Medicine (4233)
- Geriatric Medicine (394)
- Health Economics (698)
- Health Informatics (2732)
- Health Policy (1014)
- Hematology (369)
- HIV/AIDS (874)
- Medical Education (404)
- Medical Ethics (111)
- Nephrology (450)
- Neurology (4010)
- Nursing (216)
- Nutrition (594)
- Oncology (2112)
- Ophthalmology (602)
- Orthopedics (251)
- Otolaryngology (310)
- Pain Medicine (256)
- Palliative Medicine (77)
- Pathology (475)
- Pediatrics (1145)
- Primary Care Research (465)
- Public and Global Health (6630)
- Radiology and Imaging (1440)
- Respiratory Medicine (883)
- Rheumatology (418)
- Sports Medicine (350)
- Surgery (461)
- Toxicology (57)
- Transplantation (192)
- Urology (171)